DANIEL M JUNIUS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL M JUNIUS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL M JUNIUS. DANIEL M JUNIUS is a Director in IDEXX LABORATORIES INC /DE ($IDXX) and an Chief Executive Officer in IMMUNOGEN INC ($IMGN) and a Director in IMMUNOGEN INC ($IMGN) and a Director in Vitae Pharmaceuticals, Inc ($VTAE) and a Director in GLYCOMIMETICS INC ($GLYC).
Companies in which DANIEL M JUNIUS is an Insider
GLYCOMIMETICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL M JUNIUS: Director
Holdings: 38,000 shares
Current Value: $237,880
Latest Transaction: May 27 2020
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDEXX LABORATORIES INC /DE
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DANIEL M JUNIUS: Director
Holdings: 2,886 shares
Current Value: $413,073
Latest Transaction: May 14 2021
$IDXX Market Capitalization: $12.61B
$IDXX Previous Close: $143.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ImmunoGen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL M JUNIUS: Director, Chief Executive Officer
Holdings: 209,987 shares
Current Value: $499,769
Latest Transaction: Mar 16 2018
$IMGN Market Capitalization: $205.16M
$IMGN Previous Close: $2.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vitae Pharmaceuticals, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL M JUNIUS: Director
Holdings: 0 shares
Latest Transaction: Oct 25 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DANIEL M JUNIUS
Sentiment: All, GLYC, IDXX, IMGN, VTAE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 224 | 0 | 3,387 | |
| May 04 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 548.99 | 11 | 6,039 | 2,886 | 2.9 K to 2.9 K (+0.38 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 85.00 | 1,000 | 85,000 | 4,902 | |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 79.54 | 898 | 71,427 | 0 | |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 538.57 | 1,888 | 1,016,815 | 2,875 | 4.8 K to 2.9 K (-39.64 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 539.19 | 10 | 5,392 | 4,763 | 4.8 K to 4.8 K (-0.21 %) |